UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion : importance of early and complete infarct artery reperfusion

Circulation (New York, N.Y.), 1995-04, Vol.91 (7), p.1923-1928

1995

Volltextzugriff (PDF)

Historical cross-trial comparisons for competing treatments in advanced breast cancer – An empirical analysis of bias

European journal of cancer (1990), 2010-02, Vol.46 (3), p.541-548

2010

Volltextzugriff (PDF)

Assumptions, damn assumptions and statistics

Annals of oncology, 2019-09, Vol.30 (9), p.1415-1416

2019

Volltextzugriff (PDF)

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C

Annals of oncology, 2012-06, Vol.23 (6), p.1531-1536

2012

Volltextzugriff (PDF)

Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines

Annals of oncology, 2014-01, Vol.25 (1), p.117-121

2014

Volltextzugriff (PDF)

Intracerebral hemorrhage location and outcome among INTERACT2 participants

Neurology, 2017-04, Vol.88 (15), p.1408

2017

Volltextzugriff (PDF)

Clinical characteristics and outcome of patients with early (<2h), intermediate (2–4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction

European heart journal, 2002-04, Vol.23 (7), p.550-557

2002

Volltextzugriff (PDF)

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer

Annals of oncology, 2013-04, Vol.24 (4), p.937-943

2013

Volltextzugriff (PDF)

Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab

Annals of oncology, 2011-08, Vol.22 (8), p.1834-1838

2011

Volltextzugriff (PDF)

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

Annals of oncology, 2005-11, Vol.16 (11), p.1786-1794

2005

Volltextzugriff (PDF)

Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage

American journal of kidney diseases, 2016-07, Vol.68 (1), p.94-102

2016

Volltextzugriff (PDF)

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

British journal of cancer, 2011-10, Vol.105 (8), p.1144-1150

2011

Volltextzugriff (PDF)

Molecular Subgroups from the Agitg Max Trial; Right or Left Primary Site of Colorectal Cancer and Outcomes for Metastatic Colorectal Cancer (Mcrc)

Annals of oncology, 2014-09, Vol.25, p.iv173

2014

Volltextzugriff (PDF)

511PMOLECULAR SUBGROUPS FROM THE AGITG MAX TRIAL; RIGHT OR LEFT PRIMARY SITE OF COLORECTAL CANCER AND OUTCOMES FOR METASTATIC COLORECTAL CANCER (MCRC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv173-iv173

2014

Volltextzugriff (PDF)

A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer

Breast cancer research and treatment, 2011-09, Vol.129 (2), p.467-476

2011

Volltextzugriff (PDF)

Final Results of Australasian Gastro-Intestinal Trials Group (AGITG) Arctic Study: AN International Audit of Raltitrexed for Patients with Cardiac Toxicity Induced by Fluoropyrimidines (FP)

Annals of oncology, 2012-09, Vol.23, p.ix178

2012

Volltextzugriff (PDF)

A Randomised Phase II Study of Carboplatin and Bevacizumab in Recurrent Glioblastoma Multiforme (CABARET STUDY). Cooperative Trials Group For Neuro-Oncology (COGNO)

Annals of oncology, 2012-09, Vol.23, p.ix151

2012

Volltextzugriff (PDF)

532P - Pten and Advanced Colorectal Cancer (CRC): Analysis from the Phase III Agitg Max Trial of Capecitabine Alone or in Combination with Bevacizumab +/- Mitomycin C

Annals of oncology, 2012-09, Vol.23, p.ix182-ix182

2012

Volltextzugriff (PDF)

Pten and Advanced Colorectal Cancer (CRC): Analysis from the Phase III Agitg Max Trial of Capecitabine Alone or in Combination with Bevacizumab +/- Mitomycin C

Annals of oncology, 2012-09, Vol.23, p.ix182

2012

Volltextzugriff (PDF)

519O - Final Results of Australasian Gastro-Intestinal Trials Group (AGITG) Arctic Study: AN International Audit of Raltitrexed for Patients with Cardiac Toxicity Induced by Fluoropyrimidines (FP)

Annals of oncology, 2012-09, Vol.23, p.ix178-ix178

2012

Volltextzugriff (PDF)

Precision Medicine for Advanced Pancreas Cancer: Early Lessons Learned from Negotiating the Pitfalls of a Molecular Therapeutics Trial in a Poor Prognosis Cancer

Annals of oncology, 2014-09, Vol.25, p.iv563

2014

Volltextzugriff (PDF)

1628TiPPRECISION MEDICINE FOR ADVANCED PANCREAS CANCER: EARLY LESSONS LEARNED FROM NEGOTIATING THE PITFALLS OF A MOLECULAR THERAPEUTICS TRIAL IN A POOR PROGNOSIS CANCER

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv563-iv563

2014

Volltextzugriff (PDF)

Surface-normal electroabsorption reflection modulators using asymmetric Fabry-Perot structures

IEEE journal of quantum electronics, 1991-07, Vol.27 (7), p.1922-1931

1991

Volltextzugriff (PDF)

Analysis and design of surface-normal Fabry-Perot electrooptic modulators

IEEE journal of quantum electronics, 1989-11, Vol.25 (11), p.2272-2280

1989

Volltextzugriff (PDF)

Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2

European heart journal, 2007-06, Vol.28 (12), p.1418-1424

2007

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(60)
Tagungsberichte
(4)

Sprache

Englisch
(64)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(20)
Humans
(17)
Female
(15)
Aged
(14)
Middle Aged
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(12)
Oncology
(11)
Adult
(9)
Technology
(9)
Fabry-Perot
(8)
Male
(8)
Pharmacology. Drug Treatments
(8)
Engineering
(7)
Engineering, Electrical & Electronic
(7)
Optics
(7)
Physics
(7)
Tumors
(7)
Antineoplastic Agents
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion : importance of early and complete infarct artery reperfusion

Historical cross-trial comparisons for competing treatments in advanced breast cancer – An empirical analysis of bias

Assumptions, damn assumptions and statistics

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C

Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines

Intracerebral hemorrhage location and outcome among INTERACT2 participants

Clinical characteristics and outcome of patients with early (<2h), intermediate (2–4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer

Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

Molecular Subgroups from the Agitg Max Trial; Right or Left Primary Site of Colorectal Cancer and Outcomes for Metastatic Colorectal Cancer (Mcrc)

511PMOLECULAR SUBGROUPS FROM THE AGITG MAX TRIAL; RIGHT OR LEFT PRIMARY SITE OF COLORECTAL CANCER AND OUTCOMES FOR METASTATIC COLORECTAL CANCER (MCRC)

A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer

Final Results of Australasian Gastro-Intestinal Trials Group (AGITG) Arctic Study: AN International Audit of Raltitrexed for Patients with Cardiac Toxicity Induced by Fluoropyrimidines (FP)

A Randomised Phase II Study of Carboplatin and Bevacizumab in Recurrent Glioblastoma Multiforme (CABARET STUDY). Cooperative Trials Group For Neuro-Oncology (COGNO)

532P - Pten and Advanced Colorectal Cancer (CRC): Analysis from the Phase III Agitg Max Trial of Capecitabine Alone or in Combination with Bevacizumab +/- Mitomycin C

Pten and Advanced Colorectal Cancer (CRC): Analysis from the Phase III Agitg Max Trial of Capecitabine Alone or in Combination with Bevacizumab +/- Mitomycin C

519O - Final Results of Australasian Gastro-Intestinal Trials Group (AGITG) Arctic Study: AN International Audit of Raltitrexed for Patients with Cardiac Toxicity Induced by Fluoropyrimidines (FP)

Precision Medicine for Advanced Pancreas Cancer: Early Lessons Learned from Negotiating the Pitfalls of a Molecular Therapeutics Trial in a Poor Prognosis Cancer

1628TiPPRECISION MEDICINE FOR ADVANCED PANCREAS CANCER: EARLY LESSONS LEARNED FROM NEGOTIATING THE PITFALLS OF A MOLECULAR THERAPEUTICS TRIAL IN A POOR PROGNOSIS CANCER

Surface-normal electroabsorption reflection modulators using asymmetric Fabry-Perot structures

Analysis and design of surface-normal Fabry-Perot electrooptic modulators

Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2

Suchergebnisse filtern